The FDA approval follows a turbulent few weeks of public debate on the whether it is the right time for Americans to receive third booster shots

The U.S. Food and Drug Administration (FDA) has formally approved a booster dose of Pfizer’s COVID-19 vaccine for some populations in the United States. The approval allows a third Pfizer dose for those over the age of 65 and adults over 18 at high-risk of severe disease.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: , ,